Day: May 21, 2024

CALGARY, Alberta, May 21, 2024 (GLOBE NEWSWIRE) — Helium Evolution Incorporated (TSXV:HEVI) (“HEVI” or the “Company“), a Canadian-based helium exploration company focused on developing assets in southern Saskatchewan, today announced the filing of the Company’s interim condensed financial statements and associated management’s discussion and analysis for the three months ended March 31, 2024 (the “Q1 Report”). Complete details of the Q1 Report are available on SEDAR+ at www.sedarplus.ca, and on HEVI’s website. Three Months Ended March 31, 2024 Highlights:   Three months ended Tabular amounts in thousands ofCanadian Dollars, except share and per share amounts March 31, 2024 March 31, 2023 Financial     Net loss 239 311 Net loss per share, basic and diluted 0.00 0.00 Cash 5,304 8,229 Working...

Total revenues in Q1 2024 increased to $37 million compared to $16 million in the same period last year. Gross margin in Q1 2024 increased to $17 million, by $40 million compared to the same period last year. Alvotech signed new commercialization agreements for its high concentration interchangeable biosimilar to Humira® in the U.S. and for its proposed biosimilar to Prolia® and Xgeva® in the U.S. and Europe. Alvotech raises topline revenue guidance to $400-$500 million and tightens guidance for bottom line range for 2024 to $100-$150 million. Management will conduct a business update conference call and live webcast on Wednesday May 22, 2024, at 8:00 am ET (12:00 pm GMT). REYKJAVIK, Iceland, May 21, 2024 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development...

Total revenues in Q1 2024 increased to $37 million compared to $16 million in the same period last year Gross margin in Q1 2024 increased to $17 million, by $40 million compared to the same period last year. Alvotech signed new commercialization agreements for its high concentration interchangeable biosimilar to Humira® in the U.S. and for its proposed biosimilar to Prolia® and Xgeva® in the U.S. and Europe. Alvotech raises topline revenue guidance to $400-$500 million and tightens guidance for bottom line range for 2024 to $100-$150 million. Management will conduct a business update conference call and live webcast on Wednesday May 22, 2024, at 8:00 am ET (12:00 pm GMT) Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide,...

Bella Vista at Porter Ranch Northridge, CA FORT WASHINGTON, Pa., May 21, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL) (TollBrothers.com), the nation’s leading builder of luxury homes, today announced results for its second quarter ended April 30, 2024. FY 2024’s Second Quarter Financial Highlights (Compared to FY 2023’s Second Quarter): Net income and earnings per share were $481.6 million and $4.55 per diluted share, compared to net income of $320.2 million and $2.85 per diluted share in FY 2023’s second quarter. Net income and earnings per share included $124.1 million and $1.17, respectively, related to the sale of a parcel of land to a commercial developer. Excluding these gains, net income and earnings per share were $357.5 million and $3.38 per diluted share in FY 2024’s second quarter. Pre-tax income was...

(All amounts expressed in US dollars, unless otherwise stated) VANCOUVER, British Columbia, May 21, 2024 (GLOBE NEWSWIRE) — Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTC: ATCMF) today announced its financial results for the three months ended March 31, 2024, posting income from mining operations of $2.8 million and a net loss of $0.4 million. Production for the period at Atico’s El Roble mine totaled 3.3 million pounds (“lbs”) of copper and 2,185 ounces (“oz”) of gold in concentrate at a cash cost(1) of $2.57 per payable pound of copper(2). Fernando E. Ganoza, CEO and Director, commented, “the operational and financial results for this quarter were in line with Company expectations. We are already into development of the newly discovered reserves and have been making additional investments in preparation...

REIT also announces monthly distributions for Q3 2024 MONTRÉAL, May 21, 2024 (GLOBE NEWSWIRE) — Canadian Net Real Estate Investment Trust (“Canadian Net” or the “REIT”) (TSX-V: NET.UN) today reported its results for the quarter ended March 31st, 2024 (“Q1 2024”). The REIT also announced distributions for the months of July, August and September 2024. “I’m pleased to share our Q1 2024 results, which highlight the strength of our portfolio with a solid 100% occupancy rate and a conservative 57% payout ratio,” said Kevin Henley, President and CEO. “Our portfolio has performed very well and has mostly offset the increased interest rate cost due to higher rates on our 2023 mortgage renewals, translating into a slight 3% decrease in FFO per unit. Looking forward, our portfolio is well-positioned and will absorb these costs through...